Therapeutic banner
Therapeutic banner

Primary Hyperoxaluria Type 1 (PH1)

View the latest scientific data presented at congress events in the past 2 years and discover peer-reviewed publications related to PH1.
The information on this page pertains to select congress and publication resources. It is not intended to serve as a comprehensive list of all congress and publications resources.

Explore Therapeutic Areas

Congresses

View More Arrow
Congress-ASN-Mobile

Primary Hyperoxaluria Type 1 (PH1)

American Society of Nephrology (ASN) 2025

November 6-9, 2025 USA

View Details
European-Society-for-Paediatric-Nephrology,Athens,Greece-Mobile

Primary Hyperoxaluria Type 1 (PH1)

European Society for Paediatric Nephrology (ESPN) 2025

October 15-18, 2025 Greece

View Details
Compress-IPTA-Mobile

Primary Hyperoxaluria Type 1 (PH1)

International Pediatric Transplant Association (IPTA) 2025

September 18-21, 2025 Germany

View Details
Congress-AAIC-Mobile

Primary Hyperoxaluria Type 1 (PH1)

European Society for Paediatric Urology (ESPU) 2025

September 3-6, 2025 AUSTRIA

View Details
Congress-AAIC-Mobile

Primary Hyperoxaluria Type 1 (PH1)

European Renal Association (ERA) 2025

June 4-7, 2025 Austria

View Details

Publications

View More Arrow

Primary Hyperoxaluria Type 1 (PH1)

Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1

Clinical Journal of the American Society of Nephrology

Author(s)

Yaacov Frishberg, Jeffrey M. Saland, John Lieske, et al

December 2025

Primary Hyperoxaluria Type 1 (PH1)

Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-Up of the Phase 3 Illuminate-C Trial

American Journal of Kidney Diseases

Author(s)

Anne-Laure Sellier-Leclerc, Daniella Magen, Hadas Shasha-Lavsky, et al

March 2025

Primary Hyperoxaluria Type 1 (PH1)

Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial

Frontiers in Pediatrics

Author(s)

Yaacov Frishberg, Wesley Hayes, Hadas Shasha-Lavsky, et al

September 2024

Primary Hyperoxaluria Type 1 (PH1)

Reducing diagnostic delays in acute hepatic porphyria using health records data and machine learning

Journal of the American Medical Informatics Association

Author(s)

Balu Bhasuran, Katharina Schmolly, Yuvraaj Kapoor, et al

July 2024

Primary Hyperoxaluria Type 1 (PH1)

Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical Trial

Kidney International Reports

Author(s)

Jeffrey M. Saland, John C. Lieske, Jaap W. Groothoff, et al

April 2024

Primary Hyperoxaluria Type 1 (PH1)

Distinguishing characteristics of pediatric patients with primary hyperoxaluria type 1 in PEDSnet

Journal of Pediatric Urology

Author(s)

Gregory E. Tasian, Kimberley Dickinson, Grace Park, et al

February 2024